SOROS FUND MANAGEMENT DISSOLVES SHARE STAKE IN COSTCO - SEC FILING * SOROS FUND MANAGEMENT DISSOLVES SHARE STAKE IN GRAB HOLDINGS * SOROS FUND MANAGEMENT CUTS SHARE STAKE IN SANOFI BY 50% TO 200,000 ...
Sanofi (NASDAQ:SNY) has received FDA approval for Merilog, a biosimilar of Novo Nordisk's (NVO) rapid-acting insulin product NovoLog, for the improvement of glycemic control in adults and children ...
The U.S. Food and Drug Administration approved Merilog as biosimilar to Novolog for the improvement of glycemic control in adults and pediatric ...
JPMorgan raised the firm’s price target on Sanofi (SNY) to EUR 110 from EUR 105 and keeps a Neutral rating on the shares.Maximize Your ...
The job losses at the CDC are part of a broader reduction of about 5,200 positions across other government public health ...
Review of data from the trial found that the vaccine was not sufficiently effective at preventing invasive E coli disease ...
Highlights,Stratos Wealth Partners LTD. reduced its Sanofi holdings by 10.8% in the fourth quarter.,Institutional investors own 14.04% of Sanofi’s stock.,Market capitalization stands at $137.02 ...
Nielsen, 28, was diagnosed with MS aged 17 and initially believed that her athletics dreams were over due to her lack of ...
Sanofi's SNY -1.06% + Free Alerts short percent of float has fallen 8.33% since its last report. The company recently ...
Sanofi and Johnson & Johnson’s E. coli vaccine candidate failed to prevent invasive E. coli disease effectively.
Novartis NVS and AbbVie ABBV announced small M&A deals. The FDA approved the expanded use of Pfizer’s PFE cancer drug Adcetris and a tablet formulation of Roche’s R ...
Deal-starved banks lined up to make concessions to get a slice of Europe’s biggest buyout debt deal last year. They also put ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback